Xr Securities LLC Eli Lilly & CO Put Options Transaction History

Xr Securities LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $1.01 Million - $1.27 Million	-1,400 Reduced 20.59%	5,400 $4.89 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $296,100 - $396,140	-500 Reduced 6.85%	6,800 $5.29 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $420,152 - $495,304	800 Added 12.31%	7,300 $4.26 Million
Q3 2023 Oct 26, 2023	BUY	$434.7 - $599.3 $1.43 Million - $1.98 Million	3,300 Added 103.13%	6,500 $3.49 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $3.96 Million - $5.3 Million	-11,300 Reduced 77.93%	3,200 $1.5 Million
Q1 2023 May 02, 2023	BUY	$310.63 - $364.82 $3.85 Million - $4.52 Million	12,400 Added 590.48%	14,500 $4.98 Million
Q4 2022 Jan 23, 2023	BUY	$321.55 - $374.67 $675,255 - $786,807	2,100 New	2,100 $0

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.